Exclusive special offer and discount title banner vector image

GERMANY PHARMACEUTICAL LOGISTICS MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

Germany Pharmaceutical Logistics Market by Product (Branded Drugs, Generic Drugs, OTC) Market by Therapy Area (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Other Therapy Areas) Market by Type (Non-cold Chain Logistics, Cold Chain Logistics) Market by Component (Storage, Transportation, Monitoring Components)

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The Germany pharmaceutical logistics market is predicted to progress at a CAGR of 6.94% over the forecast period of 2024-2032. It is set to reach a revenue of $14986.35 million by 2032. 

The pharmaceutical logistics market in Germany is experiencing significant shifts and challenges driven by several key factors. One major trend is the surge in demand for cell and gene therapy logistics. As these innovative therapies gain prominence in the healthcare landscape, the need for specialized logistics solutions to transport and handle these sensitive and often personalized treatments is increasing. This requires advanced infrastructure, temperature-controlled environments, and strict adherence to safety protocols to ensure the efficacy and integrity of these therapies.

Digital transformation is also revolutionizing pharmaceutical logistics in Germany. The adoption of digital technologies such as blockchain, IoT (Internet of Things), and AI (Artificial Intelligence) is streamlining processes, improving visibility and traceability, and enhancing overall efficiency in supply chain management. These digital advancements enable real-time monitoring of shipments, predictive analytics for inventory management, and seamless coordination among stakeholders, contributing to faster and more reliable delivery of pharmaceutical products.

Germany Pharmaceutical Logistics Market

To Know More About This Report, Request a Free Sample Copy

Furthermore, the rising demands of clinical trial logistics are shaping the pharmaceutical logistics landscape in Germany. With an increasing number of clinical trials conducted in the country, there is a growing need for specialized logistics services to handle the transportation of investigational drugs, biological samples, and study materials. This requires adherence to rigorous regulatory requirements, stringent quality control measures, and specialized expertise in handling clinical trial materials to ensure compliance and safety throughout the supply chain.

Therefore, the pharmaceutical logistics market in Germany is undergoing transformational changes driven by the surge in demand for cell and gene therapy logistics, digital transformation initiatives, and increasing demands in clinical trial logistics. These trends are reconstructing the industry landscape and driving the need for innovative solutions and strategic partnerships to meet evolving customer and regulatory requirements.

The Germany pharmaceutical logistics market segmentation includes the market by product, therapy area, type, and component. The type segment is further divided into non-cold chain logistics and cold chain logistics. Non-cold chain logistics primarily cater to pharmaceutical products that do not require strict temperature controls during transportation and storage. These products include a wide range of medications, medical devices, and supplies that can withstand ambient temperatures without compromising their efficacy. Non-cold chain logistics prioritize efficient handling, storage, and distribution practices for pharmaceutical products. These practices focus on timely delivery and cost-effectiveness without requiring specialized temperature-controlled environments.

On the other hand, cold chain logistics are vital in the transportation and storage of temperature-sensitive pharmaceutical products. This sub-segment incorporates vaccines, biologics, blood products, and certain medications that must be maintained within specific temperature ranges to preserve their potency and integrity. Cold chain logistics involve sophisticated temperature-controlled storage facilities, refrigerated vehicles, and strict adherence to temperature monitoring and maintenance protocols throughout the supply chain. The emphasis is on preserving product quality and ensuring compliance with regulatory requirements, especially for products that are highly sensitive to temperature variations.

Some of the leading players in the Germany pharmaceutical logistics market are DSV, DB Schenker, Deutsche Post AG, FedEx, Kuehne + Nagel, etc. 

DB Schenker, a Germany-based company, offers global logistics and mobility solutions, including air and ocean freight, land transport, contract logistics, and specialized services. Operating in about 2,100 locations worldwide, they provide cost—and time-optimized freight options, with around 1,200 chartered flights yearly. With 24,500 employees in 750 locations for contract logistics, the company focuses on tailored solutions for trade and industry within the healthcare logistics industry, covering biopharma, pharmaceuticals, medTech, and more.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast Units

Revenue ($ Million)

Segments Analyzed
Product, Therapy Area, Type, and Component
Countries AnalyzedGermany
Companies AnalyzedAgility Logistics, AP Moller – Maersk, Cardinal Health, Cencora (AmerisourceBergen), CEVA Logistics, DB Schenker, Deutsche Post AG, DSV, FedEx, Kuehne + Nagel, Marken (acquired by UPS), Medline, SEKO Logistics, United Parcel Service (UPS)
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS 
    4. SCOPE OF STUDY
    5. CRISIS SCENARIO ANALYSIS
    6. MAJOR MARKET FINDINGS
      1. BRANDED DRUGS ARE THE MOST COMMONLY USED PRODUCTS IN THE PHARMACEUTICAL LOGISTICS MARKET
      2. COMMUNICABLE DISEASES HOLD THE LARGEST MARKET SHARE IN THE THERAPY AREA
      3. COLD CHAIN LOGISTICS IS THE FASTEST-GROWING TYPE WITHIN THE PHARMACEUTICAL LOGISTICS MARKET
      4. MONITORING OF PHARMACEUTICAL LOGISTICS OPERATIONS IS INCREASINGLY BECOMING A FOCUS AREA
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING NEED FOR TEMPERATURE-CONTROLLED SOLUTIONS IN PHARMACEUTICALS
      2. EXPANSION OF OCEAN FREIGHT SERVICES IN PHARMACEUTICAL INDUSTRY
      3. RISE IN CONSUMER PREFERENCE FOR OVER-THE-COUNTER MEDICINES
      4. SURGE IN PHARMACEUTICAL LOGISTICS DURING THE GERMANY COVID-19 PANDEMIC
    2. KEY RESTRAINTS
      1. RIGOROUS REGULATORY REQUIREMENTS IN PHARMACEUTICAL LOGISTICS
      2. ENSURING REAL-TIME TRANSPARENCY AND RELIABILITY IN PHARMACEUTICAL LOGISTICS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. SURGE IN DEMAND FOR CELL & GENE THERAPY LOGISTICS
      2. REVOLUTIONIZING PHARMACEUTICAL LOGISTICS THROUGH DIGITAL TRANSFORMATION
      3. INCREASING CLINICAL TRIALS LOGISTICS DEMANDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR GERMANY
    4. MARKET CONCENTRATION ANALYSIS
    5. VALUE CHAIN ANALYSIS
      1. MANUFACTURING
      2. STORAGE
      3. TRANSPORTATION
      4. DISTRIBUTION
      5. MONITORING COMPONENTS
      6. CONSUMPTION
    6. KEY BUYING CRITERIA
      1. TYPE OF LOGISTICS
      2. SERVICES OFFERED
      3. MODE OF TRANSPORTATION
      4. APPLICATION
      5. REGULATORY COMPLIANCE
      6. TECHNOLOGICAL CAPABILITIES
      7. COST
      8. RELIABILITY
      9. AGILITY
  5. MARKET BY PRODUCT
    1. BRANDED DRUGS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. GENERIC DRUGS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. OTC
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY THERAPY AREA
    1. COMMUNICABLE DISEASES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. ONCOLOGY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. DIABETES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    4. CARDIOVASCULAR DISEASES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    5. AUTOIMMUNE DISEASES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    6. NEUROLOGICAL DISORDERS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    7. PAIN MANAGEMENT
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    8. RESPIRATORY DISEASES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    9. OTHER THERAPY AREAS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY TYPE
    1. NON-COLD CHAIN LOGISTICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. COLD CHAIN LOGISTICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. MARKET BY COMPONENT
    1. STORAGE
      1. WAREHOUSE
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
      2. REFRIGERATED CONTAINERS
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
    2. TRANSPORTATION
      1. OVERLAND LOGISTICS
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
      2. SEA FREIGHT LOGISTICS
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
      3. AIR FREIGHT LOGISTICS
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
    3. MONITORING COMPONENTS
      1. HARDWARE
        1. SENSORS
          1. MARKET FORECAST FIGURE
          2. SEGMENT ANALYSIS
        2. RFID DEVICES
          1. MARKET FORECAST FIGURE
          2. SEGMENT ANALYSIS
        3. TELEMATICS
          1. MARKET FORECAST FIGURE
          2. SEGMENT ANALYSIS
        4. NETWORKING DEVICES
          1. MARKET FORECAST FIGURE
          2. SEGMENT ANALYSIS
      2. SOFTWARE
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. AGILITY LOGISTICS
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      2. AP MOLLER – MAERSK
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      3. CARDINAL HEALTH
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      4. CENCORA (AMERISOURCEBERGEN)
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      5. CEVA LOGISTICS
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      6. DB SCHENKER
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      7. DEUTSCHE POST AG
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      8. DSV
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      9. FEDEX
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      10. KUEHNE + NAGEL
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      11. MARKEN (ACQUIRED BY UPS)
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      12. MEDLINE
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      13. SEKO LOGISTICS
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      14. UNITED PARCEL SERVICE (UPS)
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL LOGISTICS

TABLE 2: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: GERMANY STORAGE MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GERMANY STORAGE MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: GERMANY TRANSPORTATION MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GERMANY TRANSPORTATION MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 14: GERMANY MONITORING COMPONENTS MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GERMANY MONITORING COMPONENTS MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 16: GERMANY HARDWARE MARKET, BY HARDWARE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GERMANY HARDWARE MARKET, BY HARDWARE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 18: LIST OF MERGERS & ACQUISITIONS

TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR GERMANY

FIGURE 4: MARKET CONCENTRATION ANALYSIS

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: GERMANY PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 8: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)

FIGURE 9: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)

FIGURE 10: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)

FIGURE 11: GERMANY PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY THERAPY AREA, IN 2023

FIGURE 12: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $ MILLION)

FIGURE 13: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 14: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)

FIGURE 15: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $ MILLION)

FIGURE 16: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $ MILLION)

FIGURE 17: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $ MILLION)

FIGURE 18: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)

FIGURE 19: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $ MILLION)

FIGURE 20: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $ MILLION)

FIGURE 21: GERMANY PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023

FIGURE 22: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 23: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 24: GERMANY PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2023

FIGURE 25: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)

FIGURE 26: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY WAREHOUSE, 2024-2032 (IN $ MILLION)

FIGURE 27: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY REFRIGERATED CONTAINERS, 2024-2032 (IN $ MILLION)

FIGURE 28: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)

FIGURE 29: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY OVERLAND LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 30: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY SEA FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 31: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY AIR FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 32: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $ MILLION)

FIGURE 33: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)

FIGURE 34: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY SENSORS, 2024-2032 (IN $ MILLION)

FIGURE 35: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY RFID DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 36: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY TELEMATICS, 2024-2032 (IN $ MILLION)

FIGURE 37: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY NETWORKING DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 38: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)

FAQ’s

Request Customization
Request Customization
Request Free Sample